Avicanna Inc. AVCN.TO

Company Overview

Avicanna Inc. is a Canadian biopharmaceutical company focused on the development, manufacturing, and commercialization of cannabinoid-based products for medical and wellness applications. The company operates within the pharmaceutical, medical cannabis, and cannabinoid research industries, with activities spanning clinical development, evidence-based cannabinoid therapeutics, and consumer health products. Its primary revenue drivers include medical cannabis formulations, proprietary cannabinoid delivery technologies, pharmaceutical development activities, and international commercial distribution agreements.

The company’s core business lines include medical cannabis products marketed under brands such as RHO Phyto, cannabinoid-based pharmaceutical research through its proprietary platforms, and international commercialization partnerships. Avicanna serves physicians, medical patients, pharmacies, and healthcare-focused distributors in multiple jurisdictions. The company has positioned itself as a research-driven cannabinoid platform emphasizing scientific validation, intellectual property development, and pharmaceutical-grade manufacturing standards. Founded in Canada and publicly listed on the Toronto Stock Exchange under the symbol AVCN, Avicanna evolved from an early-stage cannabinoid research company into a vertically integrated medical cannabinoid enterprise with clinical and commercial operations across several international markets.